|
|
||||||||
Clinical Chemistry, Vol 10, 41-52, Copyright © 1964 by the American Association for Clinical Chemistry
1 Department for Research in Human Reproduction, Michael Reese Hospital and Medical Center, Chicago 16, Ill.
Ten groups of commonly utilized medications were examined both in vitro and in vivo for their ability to interfere with optical density measurement and/or color development in such routine endocrine laboratory tests as those for 17-ketosteroids and 17-hydroxycorticosteroids. Certain antihypertensives, tranquilizers, psychic energizers, monoamine oxidase inhibitors, and soporifics were found to create the most problems in interference. The importance of removing these medications from the patients' therapeutic regimes prior to obtaining specimens for such endocrine procedures is stressed.
Submitted on December 17, 1962
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |